Deep learning enables rapid identification of potent DDR1 kinase inhibitors; Molecular sets (MOSES): a benchmarking platform for molecular generation models; Recent advances in the synthesis of Fe3O4@ AU core/shell nanoparticles; Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitors; Small-molecule PSMA ligands. Current state, SAR and perspectives; Identification of novel antibacterials using machine learning techniques; Synthesis, isomerization and biological activity of novel 2-selenohydantoin derivatives; Design, synthesis and biological evaluation of novel 5-oxo-2-thioxoimidazolidine derivatives as potent androgen receptor antagonists; AVN-322 is a safe orally bio-available potent and highly selective antagonist of 5-HT6R with demonstrated ability to improve impaired memory in animal models; Synthesis, characterisation, cytotoxicity and antibacterial activity of ruthenium (II) and rhodium (III) complexes with sulfur-containing terpyridines; Discovery of novel highly potent hepatitis C virus NS5A inhibitor (AV4025); Novel oral anti-influenza drug candidate AV5080; Identification of novel small-molecule ASGP-R ligands; 2-Pyrazol-1-yl-thiazole derivatives as novel highly potent antibacterials; Computational approaches to the design of novel 5-HT6 R ligands; Computational insight into the chemical space of plant growth regulators; Identification of pyrrolo-pyridine derivatives as novel class of antibacterials; A comprehensive insight into the chemical space and ADME features of small molecule NS5A inhibitors; Synthesis and biological evaluation of S-, O-and Se-containing dispirooxindoles; Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models. arXiv e-prints
